Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Disposition index (DI) and glucose effectiveness (S(G)) are risk factors for diabetes. However, the effect of DI and S(G) on future diabetes has not been examined in large epidemiological studies using direct measures. RESEARCH DESIGN AND METHODS: Insulin sensitivity index (S(I)), acute insulin response (AIR), and S(G) were measured in 826 participants (aged 40-69 years) in the Insulin Resistance Atherosclerosis Study (IRAS) by the frequently sampled intravenous glucose tolerance test. DI was expressed as S(I) x AIR. At the 5-year follow-up examination, 128 individuals (15.5%) had developed diabetes. RESULTS: The area under the receiver operating characteristic curve of a model with S(I) and AIR was similar to that of DI (0.767 vs. 0.774, P = 0.543). In a multivariate logistic regression model that included both DI and S(G), conversion to diabetes was predicted by both S(G) (odds ratio x 1 SD, 0.61 [0.47-0.80]) and DI (0.68 [0.54-0.85]) after adjusting for demographic variables, fasting and 2-h glucose concentrations, family history of diabetes, and measures of obesity. Age, sex, race/ethnicity, glucose tolerance status, obesity, and family history of diabetes did not have a significant modifying impact on the relation of S(G) and DI to incident diabetes. CONCLUSIONS: The predictive power of DI is comparable to that of its components, S(I) and AIR. S(G) and DI independently predict conversion to diabetes similarly across race/ethnic groups, varying states of glucose tolerance, family history of diabetes, and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 2×
“Firstphase insulin secretion compensates for the worsening of insulin sensitivity (2).”
Self-citationMartin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 2×
“Although reduced in individuals with impaired glucose tolerance (IGT) and diabetes (4,13), SG contributes to glucose tolerance even in conditions of significant insulin resistance, including diabetes (13).”
Self-citationAssessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Self-citationUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S., Selby, J., Borok, G. M., Henkin, L., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 492 · cited 2×
“To meet these aims, we used data from the Insulin Resistance Atherosclerosis Study (IRAS), a multicenter observational epidemiological study of different ethnic groups and varying states of glucose tolerance (19).”
Self-citationWELCH, S., GEBHART, S. S. P., BERGMAN, R. N., & PHILLIPS, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 337 · cited 2×
“0 [1994], Los Angeles, California, courtesy of Richard Bergman, PhD) (21).”
InfluentialSelf-citationEvaluation of proposed oral disposition index measures in relation to the actual disposition index
Retnakaran, R., Qi, Y., Goran, M. I., & Hamilton, J. K. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02841.x · Cited by 320 · cited 1×
“This product has been shown to have a modest correlation with minimal model–derived DI, to decrease as glucose tolerance status deteriorates, and to predict the development of diabetes independent of other risk factors including fasting and 2-h glucose concentrations (7,8).”
Role of Glucose Effectiveness in the Determination of Glucose Tolerance
Best, J. D., Kahn, S. E., Ader, M., Watanabe, R. M., Ni, T. C., & Bergman, R. N. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.1018 · Cited by 290 · cited 1×
“Although reduced in individuals with impaired glucose tolerance (IGT) and diabetes (4,13), SG contributes to glucose tolerance even in conditions of significant insulin resistance, including diabetes (13).”
Self-citationThe Natural Course of β-Cell Function in Nondiabetic and Diabetic Individuals
Festa, A., Williams, K., D’Agostino, R., Wagenknecht, L. E., & Haffner, S. M. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1100 · Cited by 271 · cited 1×
“In studies using direct methods, such as the frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis, this relationship is hyperbolic (2) and similar across glucose tolerance categories (3).”
Self-citationBeta cell function and its relation to insulin action in humans: a critical appraisal
Ferrannini, E., & Mari, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1381-z · Cited by 262 · cited 2×
“The hyperbolic paradigm of the minimal model–derived DI has also been criticized (10).”
Cited by
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S. C., de las Fuentes, L., He, S., Okunade, A. L., Patterson, B. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.005 · Cited by 886
“…during high-dose insulin infusion (stage 2) of the clamp procedure. function is an important risk factor for future development of type 2 diabetes (Lorenzo et al., 2010), and an improvement in b cell function after weight loss induced by Roux-en-Y gastric bypass surgery is an important…”
Scholtens, D. M., Kuang, A., Lowe, L. P., Hamilton, J., Lawrence, J. M., Lebenthal, Y., Brickman, W. J., Clayton, P., Ma, R. C., McCance, D., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2021 · Cited by 310
Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 259
“A 5-year follow-up study showed that the disposition index and glucose effectiveness were independent predictors of incident T2D after adjusting for traditional risk factors [40].”
The incretin system in healthy humans: The role of GIP and GLP-1
Holst, J. J. (2019) · Metabolism · doi:10.1016/j.metabol.2019.04.014 · Cited by 248
van Asseldonk, E. J. P., Stienstra, R., Koenen, T. B., Joosten, L. A. B., Netea, M. G., & Tack, C. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2992 · Cited by 155
Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity
Coen, P. M., Tanner, C. J., Helbling, N. L., Dubis, G. S., Hames, K. C., Xie, H., Eid, G. M., Stefanovic-Racic, M., Toledo, F. G. S., Jakicic, J. M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78016 · Cited by 150
Santaren, I. D., Watkins, S. M., Liese, A. D., Wagenknecht, L. E., Rewers, M., Haffner, S. M., Lorenzo, C., & Hanley, A. J. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092544 · Cited by 171
Self-citationYoung, K. A., Maturu, A., Lorenzo, C., Langefeld, C. D., Wagenknecht, L. E., Chen, Y. I., Taylor, K. D., Rotter, J. I., Norris, J. M., & Rasouli, N. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.10.018 · Cited by 123
Self-citationLankinen, M., Schwab, U., Kolehmainen, M., Paananen, J., Poutanen, K., Mykkänen, H., Seppänen-Laakso, T., Gylling, H., Uusitupa, M., & Orešič, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022646 · Cited by 103
“Disposition index (DI) is a product of measures of insulin sensitivity and first-phase insulin secretion which is predictive of conversion to diabetes [28,29].”
Sleep Characteristics, Mental Health, and Diabetes Risk
Boyko, E. J., Seelig, A. D., Jacobson, I. G., Hooper, T. I., Smith, B., Smith, T. C., Crum-Cianflone, N. F., & for the Millennium Cohort Study Team (2013) · Diabetes Care · doi:10.2337/dc13-0042 · Cited by 95
“All these changes have been associated with higher risk of the development of type 2 diabetes (29).”
The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans
Izzi‐Engbeaya, C., Comninos, A. N., Clarke, S. A., Jomard, A., Yang, L., Jones, S., Abbara, A., Narayanaswamy, S., Eng, P. C., Papadopoulou, D., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13460 · Cited by 94
“IVGTT-DI quantifies the ability of the β-cell to counter insulin resistance,(32) with lower baseline IVGTT-DI values independently predicting conversion from normal glucose tolerance or impaired glucose tolerance to type 2 diabetes within 5 years.(32) Therefore, our finding that kisspeptin increases GSIS and IVGTT-DI…”
Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes
Bergman, R. N., Piccinini, F., Kabir, M., Kolka, C. M., & Ader, M. (2019) · Diabetes · doi:10.2337/db19-0098 · Cited by 86
“In the Insulin Resistance Atherosclerosis Study (IRAS), reduced clearance was predictive of conversion from prediabetes to diabetes, but from that population study it was not possible to dissect the effect of low clearance from other factors, such as reduced disposition index (44).”
Self-citationPalmer, N. D., Goodarzi, M. O., Langefeld, C. D., Wang, N., Guo, X., Taylor, K. D., Fingerlin, T. E., Norris, J. M., Buchanan, T. A., Xiang, A. H., et al. (2015) · Diabetes · doi:10.2337/db14-0732 · Cited by 84
“SG varies by both physiologic and pathologic state (42) and has been shown to be predictive of conversion to T2D (43).”
Self-citationA role for exercise after bariatric surgery?
Coen, P. M., & Goodpaster, B. H. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12545 · Cited by 81
“These findings are significant as glucose effectiveness is an important contributor to glucose control [58], is an independent predictor of diabetes across racial/ethnic groups and varying degrees of obesity, and is reduced with impaired glucose tolerance, diabetes and aging [59].”
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
Amato, M. C., Vesco, R., Vigneri, E., Ciresi, A., & Giordano, C. S. D. S. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0372-x · Cited by 274
“1 3 specific genetic loci [11, 12] and the most powerful predictor of diabetes risk [13].”
Origins and History of the Minimal Model of Glucose Regulation
Bergman, R. N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.583016 · Cited by 98
Self-citationThe Measurement of Insulin Clearance
Piccinini, F., & Bergman, R. N. (2020) · Diabetes Care · doi:10.2337/dc20-0750 · Cited by 82
Self-citationPascoe, J., Hollern, D., Stamateris, R., Abbasi, M., Romano, L. C., Zou, B., O’Donnell, C. P., Garcia-Ocana, A., & Alonso, L. C. (2012) · Diabetes · doi:10.2337/db11-0991 · Cited by 74
Effects of medical therapies for acromegaly on glucose metabolism
Urbani, C., Sardella, C., Calevro, A., Rossi, G., Scattina, I., Lombardi, M., Lupi, I., Manetti, L., Martino, E., & Bogazzi, F. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0032 · Cited by 68
Prediabetes in youths: mechanisms and biomarkers
Weiss, R., Santoro, N., Giannini, C., Galderisi, A., Umano, G. R., & Caprio, S. (2017) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(17)30044-5 · Cited by 63
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Holder, T., Giannini, C., Santoro, N., Pierpont, B., Shaw, M., Duran, E., Caprio, S., & Weiss, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3345-2 · Cited by 62
“In addition, this index has been shown to predict deterioration of glucose metabolism over time in adults and children [22, 28, 29].”
Metabolic effects of adjunctive aripiprazole in clozapine‐treated patients with schizophrenia
Fan, X., Borba, C. P. C., Copeland, P. M., Hayden, D. L., Freudenreich, O., GOFF, D. C., & Henderson, D. C. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12009 · Cited by 68
Morton, G. J., Muta, K., Kaiyala, K. J., Rojas, J. M., Scarlett, J. M., Matsen, M. E., Nelson, J. T., Acharya, N., Piccinini, F., Stefanovski, D., et al. (2017) · Diabetes · doi:10.2337/db16-1351 · Cited by 60
Self-citationAcute Effect of Resistant Starch on Food Intake, Appetite and Satiety in Overweight/Obese Males
Al-Mana, N. M., & Robertson, M. D. (2018) · Nutrients · doi:10.3390/nu10121993 · Cited by 59
“The disposition index, which provides a measurement of β-cell function, was also assessed [33,34].”
Galderisi, A., Giannini, C., Weiss, R., Kim, G., Shabanova, V., Santoro, N., Pierpont, B., Savoye, M., & Caprio, S. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30235-9 · Cited by 49
“T2D is preceded by a pre-diabetic stage known as impaired glucose tolerance (IGT)(11) with a prevalence in the US pediatric population of 10–23%.”
Galderisi, A., Polidori, D., Weiss, R., Giannini, C., Pierpont, B. M., Tricò, D., & Caprio, S. (2019) · Diabetes · doi:10.2337/db19-0120 · Cited by 231
Alonso, L. C., Watanabe, Y., Stefanovski, D., Lee, E. J., Singamsetty, S., Romano, L. C., Zou, B., Garcia‐Ocaña, A., Bergman, R. N., & O'Donnell, C. P. (2012) · Obesity · doi:10.1038/oby.2012.36 · Cited by 46
Self-citationPathogenesis of type 2 diabetes risk in black Africans: a South African perspective
Goedecke, J. H., & Olsson, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13083 · Cited by 49
Santos, J. L., Yévenes, I., Cataldo, L. R., Morales, M., Galgani, J. E., Arancibia, C., Vega, J. L., Olmos, P. R., Flores, M., Valderas, J. P., et al. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0458-0 · Cited by 45
Vetrani, C., Verde, L., Colao, A., Barrea, L., & Muscogiuri, G. (2023) · Nutrients · doi:10.3390/nu15214524 · Cited by 45
“The disposition index was calculated as the product of measures of insulin sensitivity and first-phase insulin secretion, as a measure of global glucose tolerance [33].”
The Forgotten Role of Glucose Effectiveness in the Regulation of Glucose Tolerance
Dube, S., Errazuriz, I., Basu, A., & Basu, R. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0605-6 · Cited by 43
Leon‐Acuña, A., Alcala-Diaz, J. F., Delgado‐Lista, J., Torres-Peña, J. D., López-Moreno, J., Camargo, A., García‐Ríos, A., Marín, C., Gómez-Delgado, F., Caballero‐Villarraso, J., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0380-y · Cited by 43
Wei, C. H., Thyagiarajan, M., Hunt, L. P., Cox, R., Bradley, K., Elson, R., Hamilton-Shield, J. P., Stevens, M. C. G., & Crowne, E. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12575 · Cited by 39
Huang, L.-Y., Liu, C.-H., Chen, F.-Y., Kuo, C., Pitrone, P., & Liu, J. (2023) · Diagnostics · doi:10.3390/diagnostics13132158 · Cited by 54
Reproducibility and discrimination of different indices of insulin sensitivity and insulin secretion
Hudak, S., Huber, P., Lamprinou, A., Fritsche, L., Stefan, N., Peter, A., Birkenfeld, A. L., Fritsche, A., Heni, M., & Wagner, R. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258476 · Cited by 34
“This index has advantages as it is an early marker of an inadequate compensation of beta cell function [45].”
Persistent Apparent Pancreatic β-Cell Defects in Premenarchal PCOS Relatives
Torchen, L. C., Fogel, N. R., Brickman, W. J., Paparodis, R., & Dunaif, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1474 · Cited by 33
COOMBES, J. S., KEATING, S. E., MIELKE, G. I., FASSETT, R. G., COOMBES, B. K., O’LEARY, K. P., COX, E. R., & BURTON, N. W. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002768 · Cited by 32
“The Insulinogenic Index is a marker of beta cell function (14) and the Disposition Index assesses the combination of beta cell function and the ability of the body to dispose of the glucose load (15).”
Aliyu, U., Toor, S. M., Abdalhakam, I., Elrayess, M. A., Samra, A. B. A., & Albagha, O. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1591677 · Cited by 43
Maturu, A., DeWitt, P. E., Kern, P. A., & Rasouli, N. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.004 · Cited by 34
Lankinen, M. A., de Mello, V. D., Meuronen, T., Sallinen, T., Ågren, J., Virtanen, K. A., Laakso, M., Pihlajamäki, J., & Schwab, U. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202001004 · Cited by 36
Glucose Effectiveness in Obese Children: Relation to Degree of Obesity and Dysglycemia
Weiss, R., Magge, S. N., Santoro, N., Giannini, C., Boston, R. C., Holder, T. A., Shaw, M. M., Duran, E. J., Hershkop, K. J., & Caprio, S. (2015) · Diabetes Care · doi:10.2337/dc14-2183 · Cited by 33
“Indeed, reduced GE has been shown to contribute to the development of hyperglycemia in patients with T2DM (32).”
Perugini, R. A., & Malkani, S. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283446c1f · Cited by 31
Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome
Hanna, F., Wu, P., Heald, A. H., & Fryer, A. A. (2023) · BMJ · doi:10.1136/bmj-2022-071675 · Cited by 35
Petrelli, A., Cugnata, F., Carnovale, D., Bosi, E., Libman, I. M., Piemonti, L., Cuthbertson, D. D., & Sosenko, J. M. (2023) · Diabetologia · doi:10.1007/s00125-023-06034-y · Cited by 213
AbouAssi, H., Tune, K. N., Gilmore, B. F., Bateman, L. A., McDaniel, G. E., Muehlbauer, M. J., Huebner, J. L., Hoenig, H., Kraus, V. B., Clair, E. W. S., et al. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.140224 · Cited by 29
Kant, R., Verma, V. K., Patel, S. M., Chandra, R., Chaudhary, R., Shuldiner, A. R., & Munir, K. M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108627 · Cited by 30
Ilari, L., Piersanti, A., Göbl, C. S., Burattini, L., Kautzky‐Willer, A., Tura, A., & Morettini, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.789219 · Cited by 26
“secretion and insulin sensitivity and was already found to predict conversion to T2DM in a large epidemiological study (Lorenzo et al., 2010); BSR of insulin and mean area under the C-peptide concentration curve are indexes that provide a quantification of insulin secretion.”
Prystupa, K., Renklint, R., Chninou, Y., Otten, J., Fritsche, L., Hörber, S., Peter, A., Birkenfeld, A. L., Fritsche, A., Heni, M., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002909 · Cited by 24
Forbes, S., Godsland, I. F., Taylor-Robinson, S. D., Bell, J. D., Thomas, E. L., Patel, N. R., Hamilton, G., Parker, K. H., Marshall, I., Gray, C. D., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2956-3 · Cited by 28
“Our data confirm [35] diminished AIRg indicative of diminished beta cell function and disposition index in pGDM, which accords with an increased risk of type 2 diabetes [36].”
Fugmann, M., Uhl, O., Hellmuth, C., Hetterich, H., Kammer, N. N., Ferrari, U., Parhofer, K. G., Koletzko, B. V., Seißler, J., & Lechner, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128001 · Cited by 26
Pizinger, T., Kovtun, K., RoyChoudhury, A., Laferrère, B., Shechter, A., & St‐Onge, M. (2017) · Sleep Health · doi:10.1016/j.sleh.2017.10.005 · Cited by 30
Paternal bisphenol A exposure in mice impairs glucose tolerance in female offspring
Rashid, C. S., Bansal, A., Mesaros, C., Bartolomei, M. S., & Simmons, R. A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111716 · Cited by 23
“We deductively speculate that this impaired glucose tolerance in female offspring may be mediated by attenuated glucose effectiveness, which studies have shown is an independent predictor of type 2 diabetes conversion in at risk individuals (Lorenzo et al., 2010).”
Faraj, M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190124 · Cited by 25
Palmer, N. D., Okut, H., Hsu, F., Ng, M. C. Y., Chen, Y. I., Goodarzi, M. O., Taylor, K. D., Norris, J. M., Lorenzo, C., Rotter, J. I., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02203 · Cited by 23
Self-citationMurro, E. D., Giuseppe, G. D., Soldovieri, L., Moffa, S., Improta, I., Capece, U., Nista, E. C., Cinti, F., Ciccarelli, G., Brunetti, M., et al. (2023) · Nutrients · doi:10.3390/nu15194202 · Cited by 27
“The DI represents the product of measures of insulin sensitivity and the acute insulin response to glucose (AIRg, an index of first-phase insulin secretion), thus expressing the ability of β-cells to compensate for augmented insulin resistance with changes in the first-phase secretion [44].”
Systems analysis and the prediction and prevention of Type 2 diabetes mellitus
Bergman, R. N., Stefanovski, D., & Kim, S. P. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.05.007 · Cited by 24
Self-citationKuo, C., Wei, J., Yang, C.-Y., Ou, H., Wu, H., Fan, K., Wang, S., Hua, C., Hsiao, C.-H., Lee, M.-K., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0172-4 · Cited by 21
Lytrivi, M., Cauduro, C. G. D. S., Kibanda, J., Kristanto, P., Paesmans, M., & Cnop, M. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.07.018 · Cited by 21
Lorenzo, C., Williams, K. M., & Haffner, S. M. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03660.x · Cited by 22
Self-citationRevisiting the Pattern of Loss of β-Cell Function in Preclinical Type 1 Diabetes
Martino, M., Galderisi, A., Evans‐Molina, C., & Dayan, C. M. (2024) · Diabetes · doi:10.2337/db24-0163 · Cited by 21
Cyr, Y., Lamantia, V., Bissonnette, S., Burnette, M., Besse‐Patin, A., Demers, A., Wabitsch, M., Chrétien, M., Mayer, G., Estall, J. L., et al. (2021) · Physiological Reports · doi:10.14814/phy2.14721 · Cited by 20
“There were no group-differences in 1st phase or total glucoseinduced insulin secretion (p > 0.05), 1st phase or total C-peptide secretion (Figure 3c) or insulin sensitivity assessed as GIR (data not shown) or M/I during the Botnia clamp (Figure 3d).”
InfluentialAndreozzi, F., Gastaldelli, A., Mannino, G. C., Sciacqua, A., Succurro, E., Arturi, F., Folli, F. B., & Perticone, F. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.028 · Cited by 23
ALFORD, F. P., Henriksen, J. E., Rantzau, C., & Beck‐Nielsen, H. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2989 · Cited by 20
“Overall, 27% of those subjects with the lowest tertile of GE and acute insulin secretion went on to develop diabetes, whilst only 5% of those subjects in the upper tertiles developed diabetes.(45)”
Burden, H. J., Adams, S. E., Kulatea, B., Wright‐McNaughton, M., Sword, D., Ormsbee, J. J., Watene-O’Sullivan, C., Merriman, T. R., Knopp, J. L., Chase, J. G., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05552-x · Cited by 21
Mechanisms for increased risk of diabetes in chronic liver diseases
Svegliati‐Baroni, G., Gaggini, M., Carli, F., Barbieri, C., Cucco, M., Younes, R., Rosso, C., Bugianesi, E., & Gastaldelli, A. (2020) · Liver International · doi:10.1111/liv.14556 · Cited by 17
Pazderska, A., Tun, T. K., Phelan, N., McGowan, A. N., Sherlock, M., Behan, L., Boran, G. P., & Gibney, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13542 · Cited by 20
Zhang, J.-L., Li, H., Bai, N., Xu, Y., Song, Q., Zhang, L., Wu, G., Chen, S., Hou, X., Wang, C., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01018-5 · Cited by 17
Bissonnette, S., Lamantia, V., Ouimet, B., Cyr, Y., Devaux, M., RABASA-LHORET, R. P. R., Chrétien, M., Saleh, M., & Faraj, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-45870-1 · Cited by 17
Shah, S. S., Ramirez, C. E., Powers, A. C., Yu, C., Shibao, C. A., & Luther, J. M. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.011 · Cited by 15
“Multiple studies have also reported reduced insulin sensitivity in African Americans or black South Africans compared to whites [33–35].”
InfluentialKisspeptin and Glucose Homeostasis
Izzi‐Engbeaya, C. N., Hill, T. G., & Bowe, J. E. (2019) · Seminars in Reproductive Medicine · doi:10.1055/s-0039-3400242 · Cited by 15
Associations Between Glucose Tolerance, Insulin Secretion, Muscle and Fat Mass in Cystic Fibrosis
Nielsen, B. U., Faurholt‐Jepsen, D., Oturai, P., Qvist, T., Krogh‐Madsen, R., Katzenstein, T. L., Shaw, J., Ritz, C., Pressler, T., Almdal, T., et al. (2021) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514211038259 · Cited by 15
“Fasting 40 (33-49) 46 (34-61) 32 (25-41) 23 (17-32) .”
Lee, C. C., Young, K. A., Norris, J. M., Rotter, J. I., Liu, Y., Lorenzo, C., Wagenknecht, L. E., Cole, D. E. C., Haffner, S. M., Chen, Y. I., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00039 · Cited by 15
Self-citationArreola, E. V., Hanson, R. L., Bogardus, C., & Knowler, W. C. (2021) · Diabetes · doi:10.2337/db21-0416 · Cited by 15
Disposition Index in Active Acromegaly
Niculescu, D., Dușceac, R., Caragheorgheopol, A., Popescu, N. L., & Poiană, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00637 · Cited by 13
Glucose Effectiveness in Nondiabetic Relatives: Dysglycemia and β-Cell Function at 10 Years
Egede, M. B., Henriksen, J. E., Durck, T. T., Levin, K., Rantzau, C., Ward, G. M., Beck‐Nielsen, H., & ALFORD, F. P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3273 · Cited by 12
Cross-Sectional and Longitudinal Changes of Glucose Effectiveness in Relation to Glucose Tolerance
Lorenzo, C., Wagenknecht, L. E., Karter, A. J., Hanley, A. J., Rewers, M., & Haffner, S. M. (2011) · Diabetes Care · doi:10.2337/dc10-2120 · Cited by 13
“, glucose effectiveness [SG]) is an independent determinant of future diabetes in different ethnic groups and varying states of glucose tolerance, family history of diabetes, and obesity (3).”
Self-citationGlucose effectiveness and its components in relation to body mass index
Morettini, M., Nardo, F. D., Ingrillini, L., Fioretti, S., Göbl, C. S., Kautzky‐Willer, A., Tura, A., Pacini, G., & Burattini, L. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13099 · Cited by 12
Kuo, T.-Y., Wu, C., Lu, C., Lin, J., Liang, Y., Hsieh, C., Pei, D., & Chen, Y. (2020) · Medicine · doi:10.1097/md.0000000000022215 · Cited by 12
“In some studies, GE was found to be responsible for most of the glucose disappearance in T2DM.([11,12]) Surprisingly, these 3 aforementioned factors (FPIS, SPIS, and GE) are important but less studied in the past.”
Johns, I., Goff, L. M., Bluck, L. J. C., Griffin, B. A., Jebb, S. A., Lovegrove, J. A., Sanders, T. A. B., Frost, G. S., & Dornhorst, A. (2014) · Diabetic Medicine · doi:10.1111/dme.12550 · Cited by 14
Forbes, S., Lam, A. P., Koh, A., Imes, S., Dinyari, P., Malcolm, A. J., Shapiro, A. M. J., & Senior, P. A. (2018) · Clinical Transplantation · doi:10.1111/ctr.13301 · Cited by 13
“As the objective of metabolic testing is to assess graft function post hoc analyses were also performed to explore insulin secretion using ROC curves constructed using the DI < 1, a composite score reflecting defective insulin secretion in relation to the insulin sensitivity.(30,50) Such analyses confirmed the close a…”
Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop
Peters, H. P. F., Schrauwen, P., Verhoef, P., Byrne, C. D., Mela, D. J., Pfeiffer, A. F. H., Risérus, U., Rosendaal, F. R., & Schrauwen‐Hinderling, V. B. (2017) · Journal of Nutritional Science · doi:10.1017/jns.2017.13 · Cited by 12
“A recent study (61) suggests that reduced ‘ glucose effectiveness ’ , the insulin-independent component of glucose disposal comprising hepatic glucose uptake, is an important contributor to the risk of developing T2DM in a situation of increased liver fat.”
Sugimoto, H., Hironaka, K., Nakamura, T., Yamada, T., Miura, H., Otowa‐Suematsu, N., Fujii, M., Hirota, Y., Sakaguchi, K., Ogawa, W., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00819-5 · Cited by 11
“To test this hypothesis, we examined the relationship between these measures (AC_Mean and AC_Var) and established measures of glucose regulatory capacity, including the disposition index and insulin clearance, which have been reported to predict the development of future T2DM beyond FBG and plasma glucose levels at 12…”
InfluentialVahlhaus, J., Peters, B., Hornemann, S., Ost, A.-C., Kruse, M., Busjahn, A., Pfeiffer, A. F. H., & Pivovarova‐Ramich, O. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105737 · Cited by 15
“Next, the disposition index which is used as a measure of beta cell capability to compensate for insulin resistance and predicts the conversion of insulin resistance to diabetes, 47 showed a positive association with circadian time of the caloric midpoint and of the last eating event.”
Osei, K., & Gaillard, T. R. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.020 · Cited by 11
Borer, K. T. (2021) · Nutrients · doi:10.3390/nu13113812 · Cited by 13
“The level of insulin resistance in obese humans is measured by the disposition index (DI) [25].”
Su, X., Zhang, H., Yu, W., Wang, S., & Zhu, W. (2013) · The Chinese Journal of Physiology · doi:10.4077/cjp.2013.bab104 · Cited by 10
Wood, A. C., Jensen, E. T., Bertoni, A. G., Ramesh, G., Rich, S. S., Rotter, J. I., Chen, Y. I., & Goodarzi, M. O. (2021) · Metabolites · doi:10.3390/metabo11070420 · Cited by 10
“The dynamic variation of insulin secretion is well-handled by the disposition index, which estimates the adequacy of the insulin secretion response to insulin resistance [38] and is highly predictive of diabetes, both in our data and studies of others [39,40].”
Aizawa, T., Yamada, M., Katakura, M., Funase, Y., Yamashita, K., & Yamauchi, K. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0162 · Cited by 9
Zhang, H., Simpson, L. K., Carbone, N. P., Hirshman, M. F., Nigro, P., Vamvini, M. T., Goodyear, L. J., & Middelbeek, R. J. W. (2023) · iScience · doi:10.1016/j.isci.2023.107226 · Cited by 10
Hu, S., Lu, Y., Tura, A., Pacini, G., & D’Argenio, D. Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641713 · Cited by 7
Morettini, M., Castriota, C., Göbl, C. S., Kautzky‐Willer, A., Pacini, G., Burattini, L., & Tura, A. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0016 · Cited by 9
Langsford, D., Obeyesekere, V. R., Vogrin, S., Teng, J. H., MacIsaac, R. J., Ward, G. M., ALFORD, F. P., & Dwyer, K. M. (2016) · Transplantation Direct · doi:10.1097/txd.0000000000000618 · Cited by 9
Staup, M. A., Aoyagi, G., Bayless, T., Wang, Y., & Chng, K. (2016) · Journal of Visualized Experiments · doi:10.3791/52895 · Cited by 7
Sakata, S., Katsumi, S., Mera, Y., Kuroki, Y., Nashida, R., Kakutani, M., & Ohta, T. (2014) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2014.11.004 · Cited by 8
Lu, C., Teng, S., Wu, C., Hsieh, C., Chang, J., Chen, Y., Liang, Y.-J., Hsieh, P., Pei, D., & Lin, J. (2020) · Medicine · doi:10.1097/md.0000000000019562 · Cited by 7
The biological relevance of PCSK9: when less is better…
Mbikay, M., & Chrétien, M. (2022) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0540 · Cited by 7
Alkandari, S., Zafar, T. A., Al‐Sabah, S., Abu‐Farha, M., Abubaker, J. A., & Al‐Mulla, F. (2025) · Foods · doi:10.3390/foods14111905 · Cited by 8
“A lower DI indicates reduced β -cell function and an inability to compensate for IR [11].”
Measures of insulin resistance and beta cell function before and after treatment of HCV infection
Chen, J., Qiu, P., Zhao, T., Jiang, H., Tursun, K., Ksimu, S., Chen, X., & Wang, Q. (2024) · Virologica Sinica · doi:10.1016/j.virs.2024.06.007 · Cited by 5
“We also calculated three disposition indexes (DI 30, DI 60 and DI 120 ) as a measure of the β -cell response to insulin sensitivity because these indexes have been shown to predict the conversion to diabetes for evaluating β -cell function (Defronzo, 2009; Lorenzo et al., 2010; Ohn et al., 2016).”
Metadata
- Authors
- Lorenzo, C., Wagenknecht, L. E., Rewers, M. J., Karter, A. J., Bergman, R. N., Hanley, A. J. G., & Haffner, S. M.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Wake Forest University Health Sciences (US)
- University of Colorado Health (US)
- Kaiser Permanente (US)
- University of Southern California (US)
- Mount Sinai Hospital (CA)
- Baylor College of Medicine (US)
- Corresponding author
- Lorenzo, Carlos
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-09-01
- Volume
- 33
- Issue
- 9
- Pages
- 2098-2103
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2928371
- OpenAlex
- W2023961601
- Cited by
- 145
- References
- 25
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 7 · 2021: 14 · 2020: 10 · 2019: 11 · 2018: 10 · 2017: 11 · 2016: 9 · 2015: 8 · 2014: 16 · 2013: 5 · 2012: 5
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5u01hl047890-09, 5u01hl047887-09, 5u01hl047889-09)
- National Heart, Lung, and Blood Institute (U01HL047902, HL-47889, HL‐47890, HL47887, U01HL047892, HL 47892)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027619, R01DK081796, R01DK029867)
- National Center for Research Resources (M01RR01346, M01RR001346, M01-RR431)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- disposition index, glucose effectiveness, insulin sensitivity, acute insulin response, type 2 diabetes, diabetes risk prediction, insulin resistance, insulin sensitivity index, new-onset diabetes, glucose tolerance, obesity, family history of diabetes
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Middle Aged, Risk Factors, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.